vs

Side-by-side financial comparison of Digimarc CORP (DMRC) and Tonix Pharmaceuticals Holding Corp. (TNXP). Click either name above to swap in a different company.

Digimarc CORP is the larger business by last-quarter revenue ($8.9M vs $5.4M, roughly 1.7× Tonix Pharmaceuticals Holding Corp.). Digimarc CORP runs the higher net margin — -47.2% vs -870.3%, a 823.1% gap on every dollar of revenue. On growth, Tonix Pharmaceuticals Holding Corp. posted the faster year-over-year revenue change (108.8% vs 2.9%). Digimarc CORP produced more free cash flow last quarter ($895.0K vs $-41.5M). Over the past eight quarters, Tonix Pharmaceuticals Holding Corp.'s revenue compounded faster (47.4% CAGR vs -5.3%).

Digimarc Corporation is a provider of enterprise software and services. The company's software, which includes digital identifiers, is designed to address counterfeiting, product authenticity, recycling accuracy, and supply chain traceability. Digimarc products are created for multiple industries such as apparel, consumer packaged goods, health and beauty, and automotive.

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

DMRC vs TNXP — Head-to-Head

Bigger by revenue
DMRC
DMRC
1.7× larger
DMRC
$8.9M
$5.4M
TNXP
Growing faster (revenue YoY)
TNXP
TNXP
+105.9% gap
TNXP
108.8%
2.9%
DMRC
Higher net margin
DMRC
DMRC
823.1% more per $
DMRC
-47.2%
-870.3%
TNXP
More free cash flow
DMRC
DMRC
$42.4M more FCF
DMRC
$895.0K
$-41.5M
TNXP
Faster 2-yr revenue CAGR
TNXP
TNXP
Annualised
TNXP
47.4%
-5.3%
DMRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DMRC
DMRC
TNXP
TNXP
Revenue
$8.9M
$5.4M
Net Profit
$-4.2M
$-46.9M
Gross Margin
63.5%
80.4%
Operating Margin
-48.2%
-895.8%
Net Margin
-47.2%
-870.3%
Revenue YoY
2.9%
108.8%
Net Profit YoY
51.4%
-112.2%
EPS (diluted)
$-0.18
$-4.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DMRC
DMRC
TNXP
TNXP
Q4 25
$8.9M
$5.4M
Q3 25
$7.6M
$3.3M
Q2 25
$8.0M
$2.0M
Q1 25
$9.4M
$2.4M
Q4 24
$8.7M
$2.6M
Q3 24
$9.4M
$2.8M
Q2 24
$10.4M
$2.2M
Q1 24
$9.9M
$2.5M
Net Profit
DMRC
DMRC
TNXP
TNXP
Q4 25
$-4.2M
$-46.9M
Q3 25
$-8.2M
$-32.0M
Q2 25
$-8.2M
$-28.3M
Q1 25
$-11.7M
$-16.8M
Q4 24
$-8.6M
$-22.1M
Q3 24
$-10.8M
$-14.2M
Q2 24
$-9.3M
$-78.8M
Q1 24
$-10.3M
$-14.9M
Gross Margin
DMRC
DMRC
TNXP
TNXP
Q4 25
63.5%
80.4%
Q3 25
58.3%
58.4%
Q2 25
58.8%
-63.8%
Q1 25
65.0%
61.2%
Q4 24
60.8%
54.2%
Q3 24
62.4%
44.9%
Q2 24
66.1%
-52.5%
Q1 24
62.5%
33.1%
Operating Margin
DMRC
DMRC
TNXP
TNXP
Q4 25
-48.2%
-895.8%
Q3 25
-109.7%
-1005.1%
Q2 25
-105.2%
-1416.2%
Q1 25
-128.9%
-660.9%
Q4 24
-105.1%
-870.6%
Q3 24
-120.4%
-551.2%
Q2 24
-96.2%
-3501.6%
Q1 24
-109.2%
-860.2%
Net Margin
DMRC
DMRC
TNXP
TNXP
Q4 25
-47.2%
-870.3%
Q3 25
-106.9%
-972.9%
Q2 25
-102.6%
-1415.0%
Q1 25
-125.2%
-692.8%
Q4 24
-99.9%
-856.2%
Q3 24
-113.9%
-503.6%
Q2 24
-89.3%
-3567.8%
Q1 24
-104.0%
-601.9%
EPS (diluted)
DMRC
DMRC
TNXP
TNXP
Q4 25
$-0.18
$-4.28
Q3 25
$-0.38
$-3.59
Q2 25
$-0.38
$-3.86
Q1 25
$-0.55
$-2.84
Q4 24
$-0.40
$2302.65
Q3 24
$-0.50
$-22.68
Q2 24
$-0.43
$-1920.85
Q1 24
$-0.50
$-535.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DMRC
DMRC
TNXP
TNXP
Cash + ST InvestmentsLiquidity on hand
$12.9M
$207.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$40.2M
$245.2M
Total Assets
$53.0M
$277.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DMRC
DMRC
TNXP
TNXP
Q4 25
$12.9M
$207.6M
Q3 25
$12.6M
$190.1M
Q2 25
$16.1M
$125.3M
Q1 25
$21.6M
$131.7M
Q4 24
$28.7M
$98.8M
Q3 24
$33.7M
$28.2M
Q2 24
$41.5M
$4.2M
Q1 24
$48.9M
$7.0M
Total Debt
DMRC
DMRC
TNXP
TNXP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$8.7M
Q3 24
$9.4M
Q2 24
$10.1M
Q1 24
$10.8M
Stockholders' Equity
DMRC
DMRC
TNXP
TNXP
Q4 25
$40.2M
$245.2M
Q3 25
$41.4M
$231.1M
Q2 25
$46.5M
$168.0M
Q1 25
$50.0M
$180.4M
Q4 24
$61.4M
$139.6M
Q3 24
$70.2M
$74.2M
Q2 24
$77.2M
$42.1M
Q1 24
$84.5M
$108.1M
Total Assets
DMRC
DMRC
TNXP
TNXP
Q4 25
$53.0M
$277.2M
Q3 25
$55.4M
$252.4M
Q2 25
$60.7M
$187.4M
Q1 25
$66.5M
$192.9M
Q4 24
$75.8M
$162.9M
Q3 24
$85.0M
$95.0M
Q2 24
$93.4M
$70.3M
Q1 24
$99.7M
$135.3M
Debt / Equity
DMRC
DMRC
TNXP
TNXP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.06×
Q3 24
0.13×
Q2 24
0.24×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DMRC
DMRC
TNXP
TNXP
Operating Cash FlowLast quarter
$991.0K
$-39.6M
Free Cash FlowOCF − Capex
$895.0K
$-41.5M
FCF MarginFCF / Revenue
10.0%
-770.4%
Capex IntensityCapex / Revenue
1.1%
34.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.3M
$-103.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DMRC
DMRC
TNXP
TNXP
Q4 25
$991.0K
$-39.6M
Q3 25
$-2.6M
$-28.8M
Q2 25
$-4.7M
$-14.8M
Q1 25
$-5.5M
$-16.6M
Q4 24
$-4.2M
$-14.6M
Q3 24
$-7.1M
$-18.8M
Q2 24
$-6.8M
$-9.9M
Q1 24
$-8.4M
$-17.6M
Free Cash Flow
DMRC
DMRC
TNXP
TNXP
Q4 25
$895.0K
$-41.5M
Q3 25
$-2.8M
$-29.7M
Q2 25
$-4.9M
$-15.4M
Q1 25
$-5.5M
$-16.6M
Q4 24
$-4.2M
$-14.6M
Q3 24
$-7.2M
$-18.8M
Q2 24
$-6.9M
Q1 24
$-8.5M
$-17.7M
FCF Margin
DMRC
DMRC
TNXP
TNXP
Q4 25
10.0%
-770.4%
Q3 25
-36.9%
-904.1%
Q2 25
-61.0%
-768.8%
Q1 25
-59.1%
-682.8%
Q4 24
-49.1%
-566.7%
Q3 24
-75.7%
-666.5%
Q2 24
-66.1%
Q1 24
-85.8%
-712.4%
Capex Intensity
DMRC
DMRC
TNXP
TNXP
Q4 25
1.1%
34.8%
Q3 25
2.9%
29.2%
Q2 25
2.5%
26.4%
Q1 25
0.6%
0.2%
Q4 24
0.2%
0.1%
Q3 24
0.7%
0.3%
Q2 24
0.3%
0.0%
Q1 24
1.1%
4.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DMRC
DMRC

Subscription$5.3M60%
The Government$3.6M41%

TNXP
TNXP

Zembrace Symtouch$3.1M58%
Other$2.3M42%

Related Comparisons